Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2011

Open Access 01-02-2011 | Homocysteine and B-Vitamin Metabolism

Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones

Authors: Jana Kopecká, Jakub Krijt, Kateřina Raková, Viktor Kožich

Published in: Journal of Inherited Metabolic Disease | Issue 1/2011

Login to get access

Abstract

Misfolding and aggregation of mutant enzymes have been proposed to play role in the pathogenesis of homocystinuria due to cystathionine β-synthase (CBS) deficiency. Chemical chaperones have been recently shown to facilitate proper assembly of several CBS mutants. To asses the number of patients that may respond to chaperone therapy, we examined the effect of selected CBS ligands and osmolytes on assembly and activity of 27 CBS mutants that represent 70% of known CBS alleles. The mutant enzymes were expressed in a bacterial system, and their properties were assessed by native Western blotting and sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) assay, respectively. We studied the chaperoning activity of δ-aminolevulinic acid (δ-ALA)—a heme precursor—and of three osmolytes betaine, 2-aminoethanesulfonic acid (taurine), and glycerol. Fourteen mutants responded by at least 30% increase in the amount of correctly assembled tetramers and enzymatic activity to the coexpressional presence of either 0.5 mM δ-ALA, 100 mM betaine, and/or 750 mM glycerol. Eight of these mutants (p.R266K, p.P49L, p.R125Q, p.K102N, p.R369C, p.V180A, p.P78R, p.S466L) were rescuable by all of these three substances. Four mutants showed increased formation of tetramers that was not accompanied by changes in activity. Topology of mutations appeared to determine the chaperone responsiveness, as 11 of 14 solvent-exposed mutations were substantially more responsive than three of 13 buried mutations. This study identified chaperone-responsive mutants that represent 56 of 713 known patient-derived CBS alleles and may serve as a basis for exploring pharmacological approaches aimed at correcting misfolding in homocystinuria.
Appendix
Available only for authorised users
Literature
go back to reference Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM (2004) Protein misfolding in neurodegenerative diseases. Neuropathol Appl Neurobiol 30(3):215–224CrossRefPubMed Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM (2004) Protein misfolding in neurodegenerative diseases. Neuropathol Appl Neurobiol 30(3):215–224CrossRefPubMed
go back to reference Arakawa T, Ejima D, Kita Y, Tsumoto K (2006) Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. Biochim Biophys Acta 64(11):1677–1687 Arakawa T, Ejima D, Kita Y, Tsumoto K (2006) Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. Biochim Biophys Acta 64(11):1677–1687
go back to reference Bolen DW, Baskakov IV (2001) The osmophobic effect: natural selection of a thermodynamic force in protein folding. J Mol Biol 310(5):955–963CrossRefPubMed Bolen DW, Baskakov IV (2001) The osmophobic effect: natural selection of a thermodynamic force in protein folding. J Mol Biol 310(5):955–963CrossRefPubMed
go back to reference Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1(2):117–125CrossRefPubMed Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1(2):117–125CrossRefPubMed
go back to reference Caldas T, Demont-Caulet N, Ghazi A, Richarme G (1999) Thermoprotection by glycine betaine and choline. Microbiology 145(Pt 9):2543–2548PubMed Caldas T, Demont-Caulet N, Ghazi A, Richarme G (1999) Thermoprotection by glycine betaine and choline. Microbiology 145(Pt 9):2543–2548PubMed
go back to reference Chalmers RA, Lawson AM (1982) Organic acids in man. Chapman and Hall Ltd., London Chalmers RA, Lawson AM (1982) Organic acids in man. Chapman and Hall Ltd., London
go back to reference Gaustadnes M, Ingerslev J, Rutiger N (1999) Prevalence of congenital homocystinuria in Denmark. N Engl J Med 340(19):1513CrossRefPubMed Gaustadnes M, Ingerslev J, Rutiger N (1999) Prevalence of congenital homocystinuria in Denmark. N Engl J Med 340(19):1513CrossRefPubMed
go back to reference Gekko K, Timasheff SN (1981) Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 20(16):4667–4676CrossRefPubMed Gekko K, Timasheff SN (1981) Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 20(16):4667–4676CrossRefPubMed
go back to reference Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR (2005) Type 2 diabetes mellitus as a conformational disease. Jop 6(4):287–302PubMed Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR (2005) Type 2 diabetes mellitus as a conformational disease. Jop 6(4):287–302PubMed
go back to reference Holm PI, Ueland PM, Kvalheim G, Lien EA (2003) Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 49(2):286–294CrossRefPubMed Holm PI, Ueland PM, Kvalheim G, Lien EA (2003) Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 49(2):286–294CrossRefPubMed
go back to reference Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72(1):101–163PubMed Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72(1):101–163PubMed
go back to reference Janosik M, Kery V, Gaustandes M, Maclean KN, Kraus JP (2001a) Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 40(35):10625–10633CrossRefPubMed Janosik M, Kery V, Gaustandes M, Maclean KN, Kraus JP (2001a) Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 40(35):10625–10633CrossRefPubMed
go back to reference Janosik M, Oliveriusova J, Janosikova B, Sokoova J, Kraus E, Kraus JP, Kožich V (2001b) Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet 68(6):1506–1513CrossRefPubMed Janosik M, Oliveriusova J, Janosikova B, Sokoova J, Kraus E, Kraus JP, Kožich V (2001b) Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet 68(6):1506–1513CrossRefPubMed
go back to reference Janosik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kožich V (2009) Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr 154(3):431–437CrossRefPubMed Janosik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kožich V (2009) Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr 154(3):431–437CrossRefPubMed
go back to reference Kery V, Bukovska G, Kraus JP (1994) Transsulfuration depends on heme in addition to pyridoxal 5′-phosphate. Cystathionine beta-synthase is a heme protein. J Biol Chem 269(41):25283–25288PubMed Kery V, Bukovska G, Kraus JP (1994) Transsulfuration depends on heme in addition to pyridoxal 5′-phosphate. Cystathionine beta-synthase is a heme protein. J Biol Chem 269(41):25283–25288PubMed
go back to reference Kery V, Elleder D, Kraus JP (1995) Delta-aminolevulinate increases heme saturation and yield of human cystathionine beta-synthase expressed in Escherichia coli. Arch Biochem Biophys 316(1):24–29CrossRefPubMed Kery V, Elleder D, Kraus JP (1995) Delta-aminolevulinate increases heme saturation and yield of human cystathionine beta-synthase expressed in Escherichia coli. Arch Biochem Biophys 316(1):24–29CrossRefPubMed
go back to reference Kery V, Poneleit L, Kraus JP (1998) Trypsin cleavage of human cystathionine beta-synthase into an evolutionarily conserved active core: structural and functional consequences. Arch Biochem Biophys 355(2):222–232CrossRefPubMed Kery V, Poneleit L, Kraus JP (1998) Trypsin cleavage of human cystathionine beta-synthase into an evolutionarily conserved active core: structural and functional consequences. Arch Biochem Biophys 355(2):222–232CrossRefPubMed
go back to reference Kim SH, Yan YB, Zhou HM (2006) Role of osmolytes as chemical chaperones during the refolding of aminoacylase. Biochem Cell Biol 84(1):30–38CrossRefPubMed Kim SH, Yan YB, Zhou HM (2006) Role of osmolytes as chemical chaperones during the refolding of aminoacylase. Biochem Cell Biol 84(1):30–38CrossRefPubMed
go back to reference Kožich V, Kraus JP (1992) Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat 1(2):113–123CrossRefPubMed Kožich V, Kraus JP (1992) Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat 1(2):113–123CrossRefPubMed
go back to reference Kožich V, Kraus JP (2001) Homocysteine in health and disease. In: Carmel R, Jacobsen WJ (eds) Homocysteine in health and disease. Cambridge University Press, Cambridge, pp 223–244 Kožich V, Kraus JP (2001) Homocysteine in health and disease. In: Carmel R, Jacobsen WJ (eds) Homocysteine in health and disease. Cambridge University Press, Cambridge, pp 223–244
go back to reference Kožich V, Sokolová J, Klatovská V, Krijt J, Janošík M, Jelínek K, Kraus JP (2010) Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity, Hum Mutat in press doi: 10.1002/humu.21273 Kožich V, Sokolová J, Klatovská V, Krijt J, Janošík M, Jelínek K, Kraus JP (2010) Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity, Hum Mutat in press doi: 10.​1002/​humu.​21273
go back to reference Kraus J (1978) Purification and properties of cystathionine beta-synthase from human liver. J Biol Chem 253(18):6523–6528PubMed Kraus J (1978) Purification and properties of cystathionine beta-synthase from human liver. J Biol Chem 253(18):6523–6528PubMed
go back to reference Krijt J, Duta A, Kožich V (2009) Determination of S-Adenosylmethionine and S-Adenosylhomocysteine by LC-MS/MS and evaluation of their stability in mice tissues. J Chromatogr B Analyt Technol Biomed Life Sci 877(22):2061–2066CrossRefPubMed Krijt J, Duta A, Kožich V (2009) Determination of S-Adenosylmethionine and S-Adenosylhomocysteine by LC-MS/MS and evaluation of their stability in mice tissues. J Chromatogr B Analyt Technol Biomed Life Sci 877(22):2061–2066CrossRefPubMed
go back to reference Lawson-Yuen A, Levy HL (2006) The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 88(3):201–207CrossRefPubMed Lawson-Yuen A, Levy HL (2006) The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 88(3):201–207CrossRefPubMed
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275PubMed
go back to reference Mafrici B (2005) The contribution of low plasma taurine to clinical complications of Homocystinurea. Med Hypotheses 65(1):203–204CrossRefPubMed Mafrici B (2005) The contribution of low plasma taurine to clinical complications of Homocystinurea. Med Hypotheses 65(1):203–204CrossRefPubMed
go back to reference Majtan T, Singh LR, Wang L, Kruger WD, Kraus JP (2008) Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J Biol Chem 283(50):34588–34595CrossRefPubMed Majtan T, Singh LR, Wang L, Kruger WD, Kraus JP (2008) Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J Biol Chem 283(50):34588–34595CrossRefPubMed
go back to reference McCabe ERB (2001) Disorders of glycerol metabolism. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, 1631–1652 McCabe ERB (2001) Disorders of glycerol metabolism. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, 1631–1652
go back to reference Meier M, Janosik M, Kery V, Kraus JP, Burkhard P (2001) Structure of human cystathionine beta-synthase: a unique pyridoxal 5′-phosphate-dependent heme protein. EMBO J 20(15):3910–3916CrossRefPubMed Meier M, Janosik M, Kery V, Kraus JP, Burkhard P (2001) Structure of human cystathionine beta-synthase: a unique pyridoxal 5′-phosphate-dependent heme protein. EMBO J 20(15):3910–3916CrossRefPubMed
go back to reference Meier M, Oliveriusova J, Kraus JP, Burkhard P (2003) Structural insights into mutations of cystathionine beta-synthase. Biochim Biophys Acta 1647(1–2):206–213PubMed Meier M, Oliveriusova J, Kraus JP, Burkhard P (2003) Structural insights into mutations of cystathionine beta-synthase. Biochim Biophys Acta 1647(1–2):206–213PubMed
go back to reference Meng F, Park Y, Zhou H (2001) Role of proline, glycerol, and heparin as protein folding aids during refolding of rabbit muscle creatine kinase. Int J Biochem Cell Biol 33(7):701–709CrossRefPubMed Meng F, Park Y, Zhou H (2001) Role of proline, glycerol, and heparin as protein folding aids during refolding of rabbit muscle creatine kinase. Int J Biochem Cell Biol 33(7):701–709CrossRefPubMed
go back to reference Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN (2004) Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res 64(11):3790–3797CrossRefPubMed Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN (2004) Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res 64(11):3790–3797CrossRefPubMed
go back to reference Mishra R, Bhat R, Seckler R (2007) Chemical chaperone-mediated protein folding: stabilization of P22 tailspike folding intermediates by glycerol. Biol Chem 388(8):797–804CrossRefPubMed Mishra R, Bhat R, Seckler R (2007) Chemical chaperone-mediated protein folding: stabilization of P22 tailspike folding intermediates by glycerol. Biol Chem 388(8):797–804CrossRefPubMed
go back to reference Mudd SH, Levy LH, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Childs B, Vogelstein B (eds), The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill. 1007–1056 Mudd SH, Levy LH, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Childs B, Vogelstein B (eds), The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill. 1007–1056
go back to reference Ojha S, Wu J, LoBrutto R, Banerjee R (2002) Effects of heme ligand mutations including a pathogenic variant, H65R, on the properties of human cystathionine beta-synthase. Biochemistry 41(14):4649–4654CrossRefPubMed Ojha S, Wu J, LoBrutto R, Banerjee R (2002) Effects of heme ligand mutations including a pathogenic variant, H65R, on the properties of human cystathionine beta-synthase. Biochemistry 41(14):4649–4654CrossRefPubMed
go back to reference Pastores GM, Sathe S (2006) A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders. Drugs R D 7(6):339–348CrossRefPubMed Pastores GM, Sathe S (2006) A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders. Drugs R D 7(6):339–348CrossRefPubMed
go back to reference Perlmutter DH (2002) Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr Res 52(6):832–836PubMed Perlmutter DH (2002) Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr Res 52(6):832–836PubMed
go back to reference Perroud B, Le Rudulier D (1985) Glycine betaine transport in Escherichia coli: osmotic modulation. J Bacteriol 161(1):393–401PubMed Perroud B, Le Rudulier D (1985) Glycine betaine transport in Escherichia coli: osmotic modulation. J Bacteriol 161(1):393–401PubMed
go back to reference Refsum H, Fredriksen A, Meyer K, Ueland PM, Kase BF (2004) Birth prevalence of homocystinuria. J Pediatr 144(6):830–832PubMed Refsum H, Fredriksen A, Meyer K, Ueland PM, Kase BF (2004) Birth prevalence of homocystinuria. J Pediatr 144(6):830–832PubMed
go back to reference Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271(2):635–638CrossRefPubMed Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271(2):635–638CrossRefPubMed
go back to reference Schwahn BC, Hafner D, Hohlfeld T, Balkenhol N, Laryea MD, Wendel U (2003) Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol 55(1):6–13CrossRefPubMed Schwahn BC, Hafner D, Hohlfeld T, Balkenhol N, Laryea MD, Wendel U (2003) Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol 55(1):6–13CrossRefPubMed
go back to reference Shelanski ML, Gaskin F, Cantor CR (1973) Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A 70(3):765–768CrossRefPubMed Shelanski ML, Gaskin F, Cantor CR (1973) Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A 70(3):765–768CrossRefPubMed
go back to reference Singh LR, Chen X, Kozich V, Kruger WD (2007) Chemical chaperone rescue of mutant human cystathionine beta-synthase. Mol Genet Metab 91(4):335–342CrossRefPubMed Singh LR, Chen X, Kozich V, Kruger WD (2007) Chemical chaperone rescue of mutant human cystathionine beta-synthase. Mol Genet Metab 91(4):335–342CrossRefPubMed
go back to reference Skovby F, Kraus JP, Rosenberg LE (1984) Biosynthesis of human cystathionine beta-synthase in cultured fibroblasts. J Biol Chem 259(1):583–587PubMed Skovby F, Kraus JP, Rosenberg LE (1984) Biosynthesis of human cystathionine beta-synthase in cultured fibroblasts. J Biol Chem 259(1):583–587PubMed
go back to reference Tamarappoo BK, Verkman AS (1998) Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 101(10):2257–2267CrossRefPubMed Tamarappoo BK, Verkman AS (1998) Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 101(10):2257–2267CrossRefPubMed
go back to reference Verkamp E, Backman VM, Bjornsson JM, Soll D, Eggertsson G (1993) The periplasmic dipeptide permease system transports 5-aminolevulinic acid in Escherichia coli. J Bacteriol 175(5):1452–1456PubMed Verkamp E, Backman VM, Bjornsson JM, Soll D, Eggertsson G (1993) The periplasmic dipeptide permease system transports 5-aminolevulinic acid in Escherichia coli. J Bacteriol 175(5):1452–1456PubMed
Metadata
Title
Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones
Authors
Jana Kopecká
Jakub Krijt
Kateřina Raková
Viktor Kožich
Publication date
01-02-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9087-5

Other articles of this Issue 1/2011

Journal of Inherited Metabolic Disease 1/2011 Go to the issue

Homocysteine and B-Vitamin Metabolism

Choline and betaine in health and disease

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.